Shanghai Clinical Cohort - Adrenal Disease

Condition(s) studied

Investigational drug(s) / intervention(s)

Receive adrenal surgery, radiotherapy, and/or medication therapy based on diagnosis and subtype classification.: Receive adrenal surgery, radiotherapy, and/or medication therapy based on diagnosis and subtype classification.

Study summary

As a vital organ responsible for producing life-sustaining hormones, the adrenal gland is associated with a wide range of diseases. These diseases affect multiple systems throughout the body and carry a high rate of mortality and disability. Current diagnosis and treatment face several challenges: significant variability in hormone testing results, inaccurate localization via imaging techniques, unclear molecular characteristics of adrenal tumors, and difficulty in determining prognosis through pathology. Therefore, establishing a clinical research cohort for adrenal diseases is essential. Such a cohort will enable in-depth exploration of disease mechanisms, identification of disease subtypes, optimization of diagnostic criteria, evaluation of treatment efficacy, advancement of personalized medicine, and formulation of prevention and treatment strategies.

Eligibility

Primary outcome measure(s)

• Post-Treatment Remission Rate — at least six months or more
• Treatment Response Rate — at least six months or more

Trial sites (1)

More Shanghai Jiao Tong University School of Medicine trials in China